GB0809776D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0809776D0
GB0809776D0 GBGB0809776.8A GB0809776A GB0809776D0 GB 0809776 D0 GB0809776 D0 GB 0809776D0 GB 0809776 A GB0809776 A GB 0809776A GB 0809776 D0 GB0809776 D0 GB 0809776D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0809776.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amura Therapeutics Ltd
Original Assignee
Amura Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amura Therapeutics Ltd filed Critical Amura Therapeutics Ltd
Priority to GBGB0809776.8A priority Critical patent/GB0809776D0/en
Publication of GB0809776D0 publication Critical patent/GB0809776D0/en
Priority to PCT/GB2009/001319 priority patent/WO2009144450A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
GBGB0809776.8A 2008-05-29 2008-05-29 Compounds Ceased GB0809776D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0809776.8A GB0809776D0 (en) 2008-05-29 2008-05-29 Compounds
PCT/GB2009/001319 WO2009144450A1 (en) 2008-05-29 2009-05-28 Tetrahydrofuro [3, 2-b] pyrrol-3-one derivatives as inhibitors of cysteine proteases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0809776.8A GB0809776D0 (en) 2008-05-29 2008-05-29 Compounds

Publications (1)

Publication Number Publication Date
GB0809776D0 true GB0809776D0 (en) 2008-07-09

Family

ID=39637797

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0809776.8A Ceased GB0809776D0 (en) 2008-05-29 2008-05-29 Compounds

Country Status (2)

Country Link
GB (1) GB0809776D0 (en)
WO (1) WO2009144450A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2388262A1 (en) * 2010-05-20 2011-11-23 Stichting Dutch Polymer Institute New biobased chiral compounds
RS59007B1 (en) 2014-02-03 2019-08-30 Vitae Pharmaceuticals Llc Dihydropyrrolopyridine inhibitors of ror-gamma
SI3207043T1 (en) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ror-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US10301261B2 (en) 2015-08-05 2019-05-28 Vitae Pharmaceuticals, Llc Substituted indoles as modulators of ROR-gamma
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (en) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 Modulators of ror-gamma
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. Inhibitors of ror gamma
EP3658555A1 (en) 2017-07-24 2020-06-03 Vitae Pharmaceuticals, LLC Inhibitors of ror
AU2020250933A1 (en) 2019-04-05 2021-10-28 Centre Hospitalier Régional Et Universitaire De Brest Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning
KR102638391B1 (en) * 2023-05-30 2024-02-20 삼화페인트공업주식회사 Method for producing dialkanesulfonyl isosorbide compound, electrolyte additive for lithium secondary battery, electrolyte for lithium secondary battery, and lithium secondary battery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614052D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614042D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds

Also Published As

Publication number Publication date
WO2009144450A1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0804702D0 (en) Compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0812622D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0810118D0 (en) Compounds
GB0810619D0 (en) Compounds
GB0800454D0 (en) Compounds
GB0805048D0 (en) Niovel compounds
GB0800455D0 (en) Compounds
GB0800841D0 (en) Compounds
GB0800961D0 (en) Compounds
GB0801219D0 (en) Compounds
GB0810892D0 (en) Compounds
GB0807911D0 (en) Compounds
GB0808119D0 (en) Compounds
GB0807415D0 (en) Compounds
GB0811203D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)